Click For Photo: https://3c1703fe8d.site.internapcdn.net/newman/gfx/news/2019/performanceb.jpg
Roughly seven of 10 companies in the United States, if not around the globe, use some form of pay-for-performance compensation system: bonuses, commissions, piece rates, profit sharing, individual and team goal achievements, and so on. But does such an incentivized workplace create a negative effect on the mental-health wellness of those workers?
In the first big-data study combining objective medical and compensation records with demographics, researchers at Washington University in St. Louis and Aarhus University in Denmark discovered once a company switches to a pay-for-performance process, the number of employees using anxiety and depression medication increased by 5.7 percent over an existing base rate of 5.2 percent.
Number - Employees - Co-author - Lamar - Pierce
And the actual number of affected employees is almost certainly much higher, said co-author Lamar Pierce, professor of organization & strategy and associate dean for the Olin-Brookings Partnership at Olin Business School.
"This is the tip of the iceberg, and we don't know how deep that iceberg goes beneath," said Pierce, who has focused much of his Olin research on productivity, wellness and pay systems in organizations. "If you believe that the generation of significant depression and anxiety requiring medication represents a much broader shift in overall mental health, it's probably a much bigger effect in terms of people."
Impacts - Women - Age - Company - Pay-for-performance
While also finding damaging impacts on women and those over age 50 when a company changes to a pay-for-performance workplace, the key conclusion of the study, recently published online by the Academy of Management Discoveries, concentrated on the workers prescribed benzodiazepines such as Xanax or selective serotonin reuptake inhibitors (SSRIs), such as Zoloft.
Researchers Pierce and Michael S. Dahl of Aarhus University looked at comprehensive Denmark governmental records covering 318,717 full-time employees in 1,309 companies of 25-plus workers, and found—in firms implementing pay-for-performance compensation—a 5.4 percent increased likelihood that existing workers would take these medications.
This, Pierce noted, constitutes merely...
Wake Up To Breaking News!